[1]刘华雪 刘雪贞 谭赛赛 郭春梅 储华敏.体外循环心脏术后乳酸升高的影响因素及其不良健康结局的研究进展[J].心血管病学进展,2025,(2):118.[doi:10.16806/j.cnki.issn.1004-3934.2025.02.006]
 LIU Huaxue,LIU Xuezhen,TAN Saisai,et al.Factors Influencing Lactic Acid Elevation and Adverse Health Outcomes After Cardiopulmonary Bypass[J].Advances in Cardiovascular Diseases,2025,(2):118.[doi:10.16806/j.cnki.issn.1004-3934.2025.02.006]
点击复制

体外循环心脏术后乳酸升高的影响因素及其不良健康结局的研究进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2025年2期
页码:
118
栏目:
综述
出版日期:
2025-02-25

文章信息/Info

Title:
Factors Influencing Lactic Acid Elevation and Adverse Health Outcomes After Cardiopulmonary Bypass
作者:
刘华雪1 刘雪贞2 谭赛赛1 郭春梅1 储华敏1
(1.山东第一医科大学附属省立医院心外科,山东 济南 250013; 2.泰安市疾病预防控制中心慢性非传染性疾病防治科,山东 泰安 271021 )
Author(s):
LIU Huaxue1LIU Xuezhen2TAN Saisai1GUO Chunmei1CHU Huamin1
(1.Department of Cardiac Surgery,Shandong Provincial Hospital Affiliated to Shandong First Medical University,Jinan 250013,Shandong,China2.Taian Center for Disease Control and Prevention chronic non-communicable disease prevention and control section,Taian 250013,Shandong,China)
关键词:
心脏术后乳酸影响因素不良健康结局
Keywords:
Postcardiac surgery Lactic acid Influencing factor Adverse health outcomes
DOI:
10.16806/j.cnki.issn.1004-3934.2025.02.006
摘要:
高乳酸血症是体外循环心脏手术后常见的并发症,其发生与术中低灌注、组织缺氧、炎症反应、代谢紊乱、体外循环时间等多种因素有关。现旨在系统地总结和分析体外循环心脏手术后乳酸升高的原因及其对患者健康结局的影响,以此为基础,探讨可行的临床干预策略,为心脏术后乳酸升高的患者管理提供更加合理的参考和指南,并对心脏手术后的风险评估和临床干预策略的制定产生积极的推动作用。
Abstract:
Hyperlactacemia is a common complication after cardiopulmonary bypass surgery. Its occurrence is related to many factors,such as tissue hypoxia,inflammatory response and metabolic disorders,intraoperative hypoperperfusion,This paper aims to systematically summarize and analyze the causes of elevated lactic acid after cardiopulmonary bypass heart surgery and its impact on patient health outcomes,and on this basis,explore feasible clinical intervention strategies,aiming to provide a more reasonable reference and guideline for the management of patients in the later stage of cardiac surgery,and positively promote the risk assessment and the formulation of clinical intervention strategies after cardiac surgery

参考文献/References:

[1]Teixeira FC,Fernandes TEL,Leal KCDS,et al. Factors associated with increased lactate levels in cardiac surgeries:scoping review[J]. Rev Bras Enferm,2024,77(1):e20230117. [2] Broder G,Weil MH. Excess lactate:an index of reversibility of shock in human patients[J]. Science,1964,143(3613):1457-1459. [3] Bankhead-Kendall B,Slama EM,Isanaka P,et al. Predictors of operative intervention in patients with lactic acidosis[J]. Am Surg,2022,88(3):528-531. [4] Minton J,Sidebotham DA. Hyperlactatemia and cardiac surgery[J]. J ExtraCorpor Technol,2017,49(1):7-15.[5]Bhatia M,Smeltz AM,Desai CS,et al. Treatment of type B lactic acidosis with N-acetylcysteine and levocarnitine[J]. Anaesth Intensive Care,2023,51(1):75-78. [6]Zhan YF,Shi Q,Pan YC,et al. Sufentanil:a risk factor for lactic acidosis in patients after heart valve surgery[J]. J Cardiothorac Surg,2022,17(1):233.[7] Flory JH,Hennessy S,Bailey CJ,et al. Reports of lactic acidosis attributed to metformin,2015-2018[J]. Diabetes Care,2020,43(1):244-246. [8] Thammavaranucupt K,Phonyangnok B,Parapiboon W,et al. Metformin-associated lactic acidosis and factors associated with 30-day mortality[J]. PLoS One,2022,17(8):e0273678. [9] Oh HS,Chung CR,Park CM,et al. Epinephrine induced lactic acidosis during the management of anaphylactic shock:a case report[J]. Clin Exp Emerg Med,2024 May 23. DOI:10.15441/ceem.24.239. Epub ahead of print. [10] Kobayashi Y,Peng YC,Yu E,et al. Prediction of lactate concentrations after cardiac surgery using machine learning and deep learning approaches[J]. Front Med (Lausanne),2023,10:1165912.[11] Greenwood JC,Jang DH,Spelde AE,et al. Low microcirculatory perfused vessel density and high heterogeneity are associated with increased intensity and duration of lactic acidosis after cardiac surgery with cardiopulmonary bypass[J]. Shock,2021,56(2):245-254.[12] Katopodis P,Pappas EM,Katopodis KP. Acid-base abnormalities and liver dysfunction[J]. Ann Hepatol,2022,27(2):100675.[13] Smith ZR,Horng M,Rech MA. Medication-induced hyperlactatemia and lactic acidosis:a systematic review of the literature[J]. Pharmacotherapy,2019,39(9):946-963.[14] Li X,Tan T,Wu H,et al. Characteristics of sublingual microcirculatory changes during the early postoperative period following cardiopulmonary bypass-assisted cardiac surgery-a prospective cohort study[J]. J Thorac Dis,2022,14(10):3992-4002.[15] Masharani U,Strycker LA,Lazar AA,et al. Hyperlactatemia in diabetic ketoacidosis[J].?iabet Med,2022,39(4):e14723.[16] Steck DT,Jelacic S,Mostofi N,et al. The association between hypophosphatemia and lactic acidosis after cardiac surgery with cardiopulmonary bypass:a retrospective cohort study[J]. J Cardiothorac Vasc Anesth,2023,37(3):374-381.[17] K?ziora A,Wierzbicki K,Pi?ek J,et al. Postoperative hyperlactatemia and serum lactate level trends among heart transplant recipients[J].?eerJ,2020,8:e8334.[18] Jiao R,Liu M,Lu X,et al. Development and validation of a prognostic model to predict the risk of in-hospital death in patients with acute kidney injury undergoing continuous renal replacement therapy after acute type A aortic dissection[J]. Front Cardiovasc Med,2022,9:891038.[19] Aoun B,Daher GA,Daou KN,et al. Acute kidney injury post-cardiac surgery in infants and children:a single-center experience in a developing country[J]. Front Pediatr,2021,9:637463. [20] Zanza C,Facelli V,Romenskaya T,et al. Lactic acidosis related to pharmacotherapy and human diseases[J]. Pharmaceuticals (Basel),2022,15(12):1496. [21]Wang D,Wang S,Wu J,et al. Nomogram models to predict postoperative hyperlactatemia in patients undergoing elective cardiac surgery[J]. Front Med (Lausanne),2021,8:763931. [22]Odelli AL,Holyoak A,Yadav S,et al. The effect of cardiopulmonary bypass on blood thiamine concentration and its association with post-operative lactate concentration[J]. J Cardiothorac Surg,2022,17(1):260.[23] Worrell SG,Haug K,Dubovoy A,et al. Is lactic acidosis after lung transplantation associated with worse outcomes?[J]. Ann Thorac Surg,2020,110(2):434-440.[24] Klee P,Rimensberger PC,Karam O. Association between lactates,blood glucose,and systemic oxygen delivery in children after cardiopulmonary bypass[J]. Front Pediatr,2020,8:332. [25] Krasivskyi I,Djordjevic I,Tayeh M,et al. Short-term outcomes and risk factors of in-hospital mortality in patients suffering acute mesenteric ischemia after cardiac surgery:role of opioids and lactic acid[J]. J Clin Med,2023,12(3):857.[26] Chen Y,Ouyang T,Yin Y,et al. The prognosis of patients with postoperative hyperglycemia after Stanford type A aortic dissection surgery and construction of prediction model for postoperative hyperglycemia[J]. Front Endocrinol (Lausanne),2023,14:1063496. [27] Seghrouchni A,Atmani N,Moutakiallah Y,et al. Does severe hyperlactatemia during cardiopulmonary bypass predict a worse outcome?[J].?nn Med Surg (Lond),2021,73:103198. [28] Kim SG,Lee J,Yun D,et al. Hyperlactatemia is a predictor of mortality in patients undergoing continuous renal replacement therapy for acute kidney injury[J]. BMC Nephrol,2023,24(1):11.[29] Doi A,Batchelor R,Demase KC,et al. Impact of postoperative hyperlactatemia in orthotopic heart transplantation[J]. J Cardiol,2024,84(4):239-245.[30] Zheng D,Yu GL,Zhou YP,et al. Association between lactic acidosis and multiple organ dysfunction syndrome after cardiopulmonary bypass[J]. PeerJ,2024,12:e16769. [31] Zhang S,Liu W,Ganz T,et al. Exploring the relationship between hyperlactatemia and anemia[J].?rends Endocrinol Metab,2024,35(4):300-307.[32]Liu W,Zhang S,Li Q,et al. Lactate modulates iron metabolism by binding soluble adenylyl cyclase[J]. Cell Metab,2023,35(9):1597-1612.e6.[33] Ghosh-Choudhary S,Finkel T. Lactylation regulates cardiac function[J]. Cell Res,2023,33(9):653-654.[34] Hong Y,Rinehardt H,Zhu T,et al. Hyperlactatemia as a prognostic indicator for contemporary left ventricular assist device implantation[J].?en Thorac Cardiovasc Surg,2022,70(8):705-713.[35] Maulini M,Yan DJ,Buchs N,et al. [Lactate and acute mesenteric ischemia:diagnostic value][J]. Rev Med Suisse,2020,16(711):1974-1979.[36] Yagi K,Fujii T. Management of acute metabolic acidosis in the ICU:sodium bicarbonate and renal replacement therapy[J]. Crit Care,2024,28(1):110.[37] Schoenmann N,Tannenbaum N,Hodgeman RM,et al. Regulating mitochondrial metabolism by targeting pyruvate dehydrogenase with dichloroacetate,a metabolic messenger[J]. Biochim Biophys Acta Mol Basis Dis,2023,1869(7):166769. [38] Yusim D,Tiru B,Abdullin M,et al. Treatment of severe metformin-associated lactic acidosis with renal replacement therapy and tris-hydroxymethyl aminomethane:a case report[J]. J Med Case Rep,2023,17(1):462. [39] Matyukhin I,Patschan S,Ritter O,et al. Etiology and management of acute metabolic acidosis:an update[J]. Kidney Blood Press Res,2020,45(4):523-531.[40] Achanti A,Szerlip HM. Acid-base disorders in the critically ill patient[J]. Clin J Am Soc Nephrol,2023,18(1):102-112.[41] Stephens EH,Epting CL,Backer CL,et al. Hyperlactatemia:an update on postoperative lactate[J]. World J Pediatr Congenit Heart Surg,2020,11(3):316-324.[42] Akkaoui KK,Andersen LV,N?gaard MA,et al. Surviving cardiac arrest from severe metformin-associated lactic acidosis using extracorporeal membrane oxygenation and double continuous venovenous haemodialysis[J]. BMJ Case Rep,2023,16(8):e254649.[43] van Berlo-van de Laar IRF,Vermeij CG,van den Elsen-Hutten M,et al. Extracorporeal treatment of metforminassociated lactic acidosis in clinical practice:a retrospective cohort study[J]. Eur J Clin Pharmacol,2020,76(6):815-820.

相似文献/References:

[1]毛嘉豪 周帆 穆军升.酸性代谢环境对心肌细胞分化影响的研究进展[J].心血管病学进展,2024,(6):534.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.013]
 MAO JiahaoZHOU FanMU Junsheng.Influence of Acidic Metabolic Environment on?ifferentiation of Cardiomyocytes[J].Advances in Cardiovascular Diseases,2024,(2):534.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.013]

更新日期/Last Update: 2025-03-11